In recent years, digital health technologies (DHTs) have significantly changed the way we collect data within clinical trials. This is partially due to the overarching industry shift toward patient-centricity, but in some cases, it is also due to the commercial availability of powerful technology solutions not previously feasible for use in medical devices. In the past, nearly all patient data have traditionally been acquired by purpose-built machines manufactured by relatively small-scale
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Avenda Health Receives FDA Exemption for AI-Enabled Prostate Cancer Therapy
What You Should Know:
- Avenda Health, an AI healthcare company creating the future of prostate cancer care, has received FDA Investigational Device Exemption (IDE) for its FocalPoint ablation system. The IDE will allow the technology, powered by iQuest, to be used in a randomized control trial to show superiority over the standard of care for the treatment of prostate cancer.
- FocalPoint is Avenda Health’s focal laser ablation system designed to treat localized prostate cancer
Read More
Ellipsis Health & Ceras Health Integrate to Bring Human Voice as a Biomarker for Mental Health
What You Should Know:
- Ellipsis Health and Ceras Health today announced a partnership that will integrate Ellipsis Health's breakthrough technology that uses the human voice as a biomarker for mental health and wellbeing into Ceras' clinical monitoring platform.
- This integration will combine Ellipsis Health's AI and deep learning technology with Ceras Health's clinical monitoring and health data analytics platform, enabling real-time severity scores for anxiety and depression to improve
Read More
FundamentalVR Raises $20M for VR Surgical Simulation Platform
What You Should Know:
- FundamentalVR has raised an additional $20M to significantly accelerate medical skill-transfer and increase surgical proficiency through its world-leading medical simulation platform, Fundamental Surgery.
- The funding was led by EQT Life Sciences investing from the LSP Health Economics Fund 2 and joined by prior investors Downing Ventures. The new investments follow a Series A round in October 2019 and bring the
Read More
H1 Launches AI-Powered and Evidence-Based Interactions
What You Should Know:
- H1, launches an update to its flagship product, HCP Universe, the daily resource for global medical affairs and medical science liaison (MSL) teams.
- New features include a mobile app, Next-gen Smart Search capabilities built on an expansive knowledge graph, out-of-the-box insights tailored to inform MSL and Headquarter decisioning, and AI-powered notifications to improve and accelerate quality HCP engagement.
Establishing AI-Driven Efficient Workflows
H1 is
Read More
Abridge Secures $12.5M to Power AI-Powered Medical Conversations
What You Should Know:
- Abridge, the leader in medical conversation artificial intelligence (AI), today announced an oversubscribed $12.5M Series A-1 led by Wittington Ventures.
- The round also had participation from all existing investors including Union Square Ventures, Bessemer Venture Partners, Pillar Venture Capital, and UPMC Enterprises, and new investors including Turing Award winner Yoshua Bengio, and Whistler Capital.
Automated Solutions to Combat Physician
Read More
Teladoc Brings At-Home Diabetes Testing for Members
What You Should Know:
- Teladoc Health recently added an at-home A1C testing program to its chronic care solution, making it easier for members to manage their diabetes while also bridging health equity gaps in chronic condition care.
- Livongo by Teladoc Health members will have the option to receive at-home A1C tests provided by LetsGetChecked, a leading healthcare solutions company that enables providers to administer diagnostics and
Read More
Femtech Startup Nanopath Raises $10M to Develop POC Diagnostics for Women’s Health
What You Should Know:
- Nanopath, a molecular diagnostics company enabling high-quality molecular testing in minutes raises $10M in Series A funding, co-led by co-led by Norwest Venture Partners and Medtech Convergence Fund, to develop a point-of-care diagnostics platform for women’s health screenings.
- The company plans to use the latest round of funding to support development and commercialization of Nanopath's biosensing platform that aims to transform how women's pelvic and
Read More
Intel Invests $20M in Biofourmis’ Virtual Care Offerings
What You Should Know:
- Biofourmis, a Boston-based global leader in virtual care and digital medicine, today announced that Intel Capital, the strategic investment arm of chipmaker Intel Corporation, has joined its Series D financing in an extension that brings the total funding raised in the round to $320M.
- The initial Series D funding round was announced in April and was led by global growth equity firm General Atlantic with participation by CVS Health (NYSE:CVS), Trevor
Read More
Cybercriminals Use Bots to Steal Active Pharmacy Accounts and Resell Prescriptions
What You Should Know:
- Cybercriminals are leveraging illegal bots to steal pharmacy accounts and resell prescriptions on a secondary market for in-demand substances, like Oxycodone, according to recent research from Kasada’s threat intelligence team.
has recently shared research by its threat intelligence team about a new, illegal use of bots -.
- Researchers have also identified an acceleration in this activity: over the past 60 days, the number of stolen pharmacy accounts available
Read More
